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Abstract 
Objectives 
We studied the association between secondhand smoke (SHS) exposure and peripheral 
arterial disease (PAD) in Chinese non-smokers. 
Methods 
We conducted a cross-sectional study using baseline data from the Guangzhou Biobank 
Cohort Study: Cardiovascular Disease Sub-cohort Study (GBCS-CVD). Guangzhou residents 
aged ≥50 years were recruited between 2003 and 2008. Baseline data included measurement 
of ankle brachial pressure index (ABPI) and self-reported smoking status and SHS exposure. 
Univariate and multivariate logistic regression analyses were used to analyse the association 
between SHS and PAD (defined as ABPI<0.9).  
Results 
Of the 1,507 non-smokers, 24 (1.6%) had PAD. Of these, 12 were men and 12 women. 
Exposure to SHS at home of ≥25 hours per week, was reported by 16.7% of PAD cases 
compared with 3.8% of those without PAD (χ2 test, p=0.003). After adjustment for potential 
confounders, exposure to ≥25 hours per week at home was still associated with PAD 
(adjusted OR 7.86, 95% CI 2.00-30.95, p=0.003), with suggestion of a dose-response 
relationship.   
Conclusion 
Our results extend the US Surgeon General’s 2006 report that SHS exposure is an 
independent risk factor for PAD. National smoke-free legislation is needed to protect all 
people from exposure.  
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Introduction 
 
China is the world’s largest producer and consumer of tobacco. Forty-two percent of the 
world’s cigarettes are produced by China and 30% of the world’s cigarettes are consumed by 
350 million Chinese smokers.1 Smoking prevalence is decreasing in developed countries, 
such as Western Europe and North America. However, global prevalence is still increasing 
due to increasing prevalence in large, developing countries such as China.2, 3 In the absence 
of new policies and changes in cessation rates, the global number of smokers is predicted to 
increase to 872 million by 2030.4 
 
The US Surgeon’s General’s (USSG) report from 2010 has reported that the evidence 
supports that active smoking causes atherosclerotic diseases, including peripheral arterial 
disease (PAD).5 Side-stream smoke, from burning cigarette tips, is particularly injurious to 
the vascular system. It contains higher concentrations of small, respirable particles (<2.5μm) 
and toxic gases than mainstream smoke inhaled by active smokers.6-8 Thirty minutes of 
exposure can significantly reduce coronary flow velocity reserve in healthy non-smokers.9  
 
The USSG 2006 report describing the health implications of secondhand smoke (SHS) also 
states that there is sufficient evidence to show that SHS exposure causes coronary heart 
disease (CHD).10 However, although there is evidence to support increased risk of PAD in 
those exposed to SHS, 11-13 it remains inadequate to show SHS causes PAD.   
 
Indeed, to date there have only been four published studies that have examined the 
association between SHS exposure and PAD 11-14 and only one of these was conducted in 
Asia.11 Using UK data, we have previously shown an overall association between SHS 
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exposure and PAD,12 and a dose relationship between cotinine concentration and risk of 
intermittent claudication in non-smokers with 9.2% of cases of intermittent claudication 
attributable to cotinine concentrations ≥0.7ng/mL.13 The current study aimed to further assess 
the association between SHS and PAD in older Chinese. 
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Methods 
 
Data source 
The Guangzhou Biobank Cohort Study is an ongoing, general population cohort of older 
adults living in Guangzhou, south China. The methods have been reported in detail 
previously.15 A community social and welfare association, The Guangzhou Health and 
Happiness Association for the Respectable Elders (GHHARE), was chosen as the sampling 
frame. The association, with around 100,000 members, has branches throughout Guangzhou 
and membership is open to individuals aged ≥50 years for a nominal fee. From 2003 to 2008, 
30,519 eligible participants were randomly selected from the association’s membership list 
and constituted the Guangzhou Biobank Cohort.16 The Guangzhou Biobank Cohort Study 
was approved by the Guangzhou Medical Ethics Committee of the Chinese Medical 
Association. Written informed consent was collected from all participants.  
 
At baseline, all participants completed a questionnaire to provide information on 
demographics (including age, sex, occupation and education), lifestyle (including smoking 
status, exposure to SHS, alcohol intake and physical activity) and personal and family 
medical history. Trained research staff measured height and weight and obtained blood 
samples for assays.16 
 
A sub-group of 1,996 participants were randomly selected from subjects in the third phase of 
recruitment in the main cohort.16 This subgroup took part in the Guangzhou Biobank Cohort 
Study-Cardiovascular Disease Sub-cohort Study (GBCS-CVD) which collected more detailed 
information relevant to cardiovascular disease. Additional measurements included brachial 
systolic and diastolic blood pressure, and ankle systolic blood pressure in the dorsalis pedis 
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and posterior tibial arteries in both legs. The present study used the baseline data from 
GBCS-CVD.  
 
Inclusion criteria and definitions 
Our study was restricted to participants who reported themselves as non-smokers; defined as 
either never or ex-smokers. The ankle brachial pressure index (ABPI) was calculated for each 
leg as the ratio of the highest measurement of ankle systolic blood pressure (either dorsalis 
pedis or posterior tibial artery) to the brachial systolic blood pressure. PAD was defined as an 
ABPI <0.9 in at least one leg.17 The level of SHS exposure was self-reported. Participants 
reported their exposure as hours exposed per week at home and at work and the number of 
cohabitants who smoked. We classified their overall duration of exposure at home or at work 
as: none, <25 or ≥25 hours per week.18 Occupation was categorized into official/manager, 
technician/seller/police, farmer/worker, other and non/housewife. Alcohol consumption was 
self-reported and classified as never/< once per month and ≥ once per month. Physically 
active was defined as self-report of moderate or vigorous activity on at least four days during 
the previous week. Body mass index (BMI) was categorized into normal weight (<25 kg/m2), 
overweight (25-30 kg/m2) and obese (≥30 kg/m2). Dyslipidemia was defined as a total 
cholesterol concentration ≥5.2mmol/L and/or triglyceride concentration ≥1.7 mmol/L and/or 
high-density lipoprotein concentration <1.0 mmol/L and/or low-density lipoprotein 
concentration ≥3.3 mmol/L. Hypertension was defined as a blood pressure measurement of > 
140/90 mmHg or self-reported history of medications. Personal history of diabetes and family 
history of coronary heart disease (CHD) and stroke were based on self-report of a physician 
diagnosis.   
 
Statistical analyses 
 
 
8 
 
Categorical and ordinal data were summarized using frequencies and percentages. Chi-square 
tests for trend were applied to ordinal variables and Chi-square tests to categorical variables 
respectively. Univariate and multivariate logistic regression models were used to examine the 
association between levels of SHS exposure and PAD using no exposure as the referent 
category. Several hierarchical models with different level of statistical adjustment were 
developed: unadjusted, partially adjusted (age, sex and occupation) and fully adjusted 
(partially adjusted model plus alcohol intake, physical activity, BMI category, dyslipidemia, 
diabetes, hypertension and family history of CHD or stroke). All statistical analyses were 
undertaken using Stata v12.0 (Stata Corporation, College Station, Texas, USA). 
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Results 
 
Of the 1,996 individuals who participated in the cardiovascular disease sub-cohort study 
(GBCS-CVD), 1,921 (96.2%) had a valid ABPI measurement. Among these, 1,507 (78.4%) 
were non-smokers and included in this study. Of these, 1,121 (74.4%) reported themselves as 
never smokers and 386 (25.6%) as ex-smokers. Of the latter, 369 (95.6%) had quit smoking 
for more than one year. Twenty four (1.6%) of the non-smokers had PAD. Participants with 
PAD were significantly more likely to be overweight or obese (Table 1). There were no 
significant differences between the participants with and without PAD in terms of age, sex, 
occupation, alcohol intake, physical activity, diabetes, dyslipidemia, hypertension and family 
history of CHD or stroke (Table 1).  
 
The tests for trend across increasing exposure, measured by number of smoking cohabitants, 
hours of SHS exposure at home and at work were all non-significant (Table 2). However, a 
direct comparison between the high exposure and no exposure groups achieved significance 
using all three measures: ≥2 cohabitants (χ2 test, p=0.017); ≥25 hours per week at home (χ2 
test, p=0.003); ≥25 hours of exposure per week at work (χ2 test, p=0.039). Similarly, on 
univariate logistic regression analyses, participants with PAD were significantly more likely 
to report cohabitation with two or more smokers and SHS exposure of at least 25 hours at 
home and work (Table 3). After adjustment for age, sex and occupation, the association with 
two or more smoking cohabitants remained statistically significant (OR 4.72, 95% CI 1.40-
15.88, p=0.012), as did the association with exposure in the home of at least 25 hours per 
week (OR 7.96, 95% CI 2.09-30.34, p=0.002) (Table 3). Further adjustment for other 
potential confounders barely changed the odds ratios and they remained statistically 
significant (Table 3). In relation to exposure at home, there was also evidence of a possible 
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dose response relationship (p=0.013) (Table 3). There were no significant interactions with 
any of the covariates included in the models; for example p=0.824 for age and p=0.264 for 
sex.   
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Discussion 
 
We found a statistically significant association between SHS exposure at home and PAD, 
independent of potential confounding factors, with evidence of a dose response relationship.  
 
The USSG states that active smoking is a causal determinant of PAD.5 Likewise stated that 
SHS causes CHD.10 However, currently, only four published studies have examined the 
association between SHS exposure and PAD and thus evidence is lacking to infer causality.11-
14 The first study to show this association was a cross-sectional study conducted in Beijing, 
North China among 1,209 women aged ≥60 years who had never smoked. Overall, 22% of 
the women had PAD and 40% reported exposure to SHS. Women with PAD (22.4%) were 
more likely to report SHS exposure (adjusted OR 1.67, 95% CI 1.23-2.16, p<0.001). They 
also demonstrated evidence of a dose response relationship with the number of cigarettes 
exposed per day for intermittent claudication (IC), ABPI<0.9 or either (p values for 
trend=0.009, 0.002 and 0.002 respectively) and with daily duration of exposure (p values for 
trend=0.003, 0.048 and 0.001 respectively).10 The second cross-sectional study on 5,653 non-
smokers in the USA found no significant association between overall SHS exposure (defined 
as cotinine 0.05-10 ng/mL) and PAD (defined as ABPI<0.9). However, a significantly 
increased risk of PAD was found in the highest decile of cotinine levels (>155 ng/mL), a 
more reliable indicator of SHS exposure.11 Our recent cross-sectional study examined 5,686 
never smokers in Scotland, of whom 31.1% reported ever exposed to SHS. Individuals with 
ABPI<0.9 were significantly more likely to report high SHS exposure at work and a high 
overall duration of exposure (adjusted ORs: 3.82, 95%CI 1.11-13.12, p=0.034; 5.56, 95%CI 
1.82-17.06, p=0.003 respectively).12 In another cross-sectional study using the Scottish 
Health Survey, a pan-Scotland study with salivary cotinine measurements, we studied 4,231 
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non-smokers aged >45 years and showed similar findings. Individuals with a cotinine ≥2.7 
ng/mL were significantly more likely to have IC (adjusted OR 1.76, 95%CI 1.04-3.00, 
p=0.036) compared with those with cotinine <0.7 ng/mL. Overall, 9.2% of IC cases in this 
study were attributable to raised cotinine concentrations. The dose-response relationship was 
stronger among those aged <60 years (adjusted p values for trend <0.001).13 In this present 
study, we also observed a dose response relationship across different exposure levels and the 
association was statistically significant for ≥25 hours of SHS exposure per week.  
 
The present study used data from the GBCS-CVD. In order to maximize statistical power, we 
analyzed never and ex-smokers together as non-smokers. The majority (95.6%) of ex-
smokers had quit smoking for at least 1 year before the recruitment. This is the first study 
including men and women so far to examine SHS and PAD in Chinese and the first to 
examine SHS and PAD in southern Chinese. In our study, exposure to SHS was based on 
self-report, as it was in two previously published papers using this cohort.19,20 We were not 
able to corroborate self-report using objective measurements such as cotinine concentration. 
Also in common with the previous studies, we had to analyze exposure to home and exposure 
at work separately. We were unable to analyze overall exposure for two reasons. Firstly, 
participants were not asked to report exposure in other locations. Secondly, 8.2% of 
participants had missing data on exposure at home and 8.4% on exposure at work, but 13.9% 
had missing data on one or other reducing statistical power in an already small study.  
 
We were able to define PAD on the basis of ABPI measurement rather than self-reported 
symptoms.13 Clairotte et al. have suggested that the sensitivity of PAD could be increased by 
changing the definition to ABPI<1.0. 21 However, the subsequent report by the American 
Heart Association concluded that ABI≤0.9 remains the “most common and consensual 
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threshold.” 22 Similarly, in our recent review of published studies on active smoking and PAD 
23, ABPI<0.9 was the most commonly used definition. Participants were randomly selected 
from an association with branches throughout Guangzhou and should be reasonably 
representative of the relatively healthy general population in Guangzhou. We were able to 
adjust for many potential confounders including age, sex, occupation, diabetes, hypertension 
and dyslipidemia. The results reached statistically significance. However, because of small 
numbers of PAD cases, some confidence intervals were wide and, therefore, the precision of 
our estimates of effect size was low. Because of the small size of the study, the results should 
be interpreted accordingly and should be corroborated in future larger studies or meta-
analyses.  Like all previous studies, our study was cross-sectional. Therefore, a temporal 
relationship could not be established but reverse causation is unlikely.  
 
The World Health Organization’s Framework Convention on Tobacco Control (FCTC) has 
emphasized the need for effective legislation to protect against exposure to SHS in indoor 
public places.24 In China, public awareness of the health risks associated with SHS exposure 
is low.25-27 A Chinese nationally representative household survey reported that, among non-
smokers aged ≥15 years, 556 million (72.4%) were exposed to SHS, and 50% were exposed 
daily. Exposure in public places, households and indoor workplaces was 72.7%, 67.3% and 
63.3% respectively.1 The FCTC came into force in China in 2006.28 Initially, smoke-free 
legislation, prohibiting smoking in public places, was adopted by only seven cities.29 
Subsequently, Beijing, Shanghai and Guangzhou have also enacted local regulations 
prohibiting smoking in public places.30 The USSG states that evidence is sufficient to state 
that smoking causes cardiovascular diseases5 and that SHS exposure causes CHD.10 Our 
study adds to the limited published evidence supporting an association between SHS 
exposure and PAD. National smoke-free legislation is needed to protect all people from SHS 
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exposure. 
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Table 1. Characteristics of non-smokers by presence or absence of peripheral arterial 
disease 
 
    
 PAD 
N=24 
N (%) 
No PAD 
N=1,483 
N (%) 
P value* 
    
Age (years)     
<60 14 (58.3) 931 (62.8) 0.665 
≥60  10 (41.7) 552 (37.2)  
Missing  0 0  
Sex    
Male 12 (50.0) 567 (38.2) 0.240 
Female 12 (50.0) 916 (61.8)  
Missing  0 0  
Occupation     
Official/manager  10 (41.7) 549 (37.0) 0.730 
Technician/seller/police  5 (20.8) 204 (13.8)  
Farmer/worker  1 (4.2) 157 (10.6)  
Other   5 (20.8) 272 (18.3)  
None/housewife  3 (12.5) 288 (19.4)  
Missing   0 13  
Alcohol intake in last year   
Never - <1/month  15 (62.5) 935 (64.3) 0.731 
≥1/month  5 (20.8) 228 (15.4)  
Missing   4 302  
Physical activity in last week   
≥4 days  11 (45.8) 598 (40.3) 0.773 
≤3 days  13 (54.2) 869 (58.6)  
Missing   0 16  
Body mass index    
Normal  11 (45.8) 1,007 (67.9) 0.009 
Overweight  11 (45.8) 439 (29.6)  
Obese  2 (8.3) 35 (2.4)  
Missing  0 2  
Diabetes     
No 23 (95.8) 1,434 (96.7) 0.920 
Yes  1 (4.2) 45 (3.0)  
Missing  0 4 (0.3)  
Total cholesterol (mmol/L)    
≤5.2 6 (25.0) 397 (26.8) 0.965 
>5.2  18 (75.0) 1,084 (73.1)  
Missing  0 2  
Triglyceride (mmol/L)    
<1.7 13 (54.2) 936 (63.1) 0.658 
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≥1.7 11 (45.8) 546 (36.8)  
Missing  0 1  
HDL cholesterol (mmol/L)    
≥1.0  23 (95.8) 1,438 (97.0) 0.936 
<1.0  1 (4.2) 44 (3.0)  
Missing  0 1  
LDL cholesterol (mmol/L)    
<3.3  10 (41.7) 715 (48.2) 0.808 
≥3.3  14 (58.3) 767 (51.7)  
Missing  0 1  
Hypertension    
No 17 (70.7%) 969 (65.3%) 0.835 
Yes 7 (29.2%) 510 (34.4%)  
Missing  0 4  
Family history of CHD or stroke    
No 19 (79.2) 1,263 (85.2) 0.413 
Yes  5 (20.8) 220 (14.8)  
Missing  0 0  
    
 
PAD peripheral arterial disease; N number; HDL high-density lipoprotein; LDL low-density 
lipoprotein; CHD coronary heart disease 
* χ2 tests for age, sex, occupation, alcohol intake in last year, physical activity in last week, 
diabetes, total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, hypertension, 
family history of CHD or stroke; χ2 tests for trend for body mass index 
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Table 2. Self-reported secondhand smoke exposure among non-smokers by presence or 
absence of peripheral arterial disease 
 
 
*χ2 tests for trend    
 
 
 
     
  PAD No PAD P value * 
  N=24 N=1,483  
  N (%) N (%)  
     
Number of cohabitants who smoke    
 None  11 (45.8) 758 (51.1) 0.162 
 1 9 (37.5) 651 (43.9)  
 ≥2 4 (16.7) 73 (4.9)  
 Missing  0 1  
Hours of exposure / week at home    
 None 11 (45.8) 756 (51.0) 0.115 
 <25 7 (29.2) 547 (36.9)  
 ≥25 4 (16.7) 56 (3.8)  
 Missing 2 124  
Hours of exposure / week at work    
 None 10 (41.7) 585 (39.5) 0.222 
 <25 7 (29.2) 652 (44.0)  
 ≥25 6 (25.0) 124 (8.4)  
 Missing 1 122  
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Table 3. Logistic regression analyses of the association between self-reported secondhand smoke exposure and peripheral arterial disease 
among non-smokers 
 
          
  Univariate  Partially adjusted*   Fully adjusted**   
  OR (95% CI) P value P value 
for trend 
OR (95% CI) P value P value 
for trend 
OR (95% CI) P value P value 
for trend 
           
Number of cohabitants who smoke          
None 1.00  0.164 1.00  0.040 1.00  0.054 
1 0.95 (0.39-2.31) 0.915  1.31 (0.48-3.53) 0.598  1.23 (0.45-3.35) 0.689  
≥2 3.78 (1.17-12.16) 0.026  4.72 (1.40-15.88) 0.012  4.52 (1.32-15.52) 0.017  
          
Hours of exposure / week at home          
None 1.00  0.118 1.00  0.009 1.00  0.013 
<25 0.88 (0.34-2.28) 0.792  1.30 (0.45-3.74) 0.630  1.23 (0.42-3.59) 0.704  
≥25 4.91 (1.51-15.91) 0.008  7.96 (2.09-30.34) 0.002  7.86 (2.00-30.95) 0.003  
          
Hours of exposure / week at work          
None 1.00  0.224 1.00  0.549 1.00  0.623 
<25 0.63 (0.24-1.66) 0.348  0.47 (0.17-1.31) 0.150  0.48 (0.17-1.35) 0.164  
≥25 2.83 (1.01-7.93) 0.048  2.00 (0.66-6.05) 0.217  1.93 (0.61-6.07) 0.261  
           
 
OR odds ratio; CI confidence interval 
*adjusted for age, sex and occupation 
**adjusted for age, sex, occupation, alcohol intake, physical activity, BMI category, total cholesterol, triglyceride, HDL-cholesterol, LDL-
cholesterol, hypertension, diabetes, family history of CHD or stroke 
 
